Total investments received (USD): 24.38m
Round value (USD): N/A
Company: Hoba Therapeutics
Industry:
Biotech
Health services


Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom